Literature DB >> 18269319

Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome.

Ana Saksida1, Darja Duh, Misa Korva, Tatjana Avsic-Zupanc.   

Abstract

To asses the role of virus load in the pathogenesis of hemorrhagic fever with renal syndrome, the serum Dobrava virus RNA load in 46 patients was measured with a novel quantitative real-time reverse-transcriptase polymerase chain reaction assay and compared to the disease severity. The level of viremia, detected in 26 patients, ranged from 10(2)-10(8) copies/mL of serum. The patients with severe disease had, on average, higher viral RNA loads than patients with a milder course of disease (6.15 vs. 4.67 log(10) copies/mL; P = .053). These results suggest that the Dobrava virus load might be associated with the severity of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18269319     DOI: 10.1086/527485

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.

Authors:  Ana Saksida; Darja Duh; Branka Wraber; Isuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

2.  Multiple co-infections of rodents with hantaviruses, Leptospira, and Babesia in Croatia.

Authors:  Ante Tadin; Nenad Turk; Miša Korva; Josip Margaletić; Relja Beck; Marko Vucelja; Josipa Habuš; Petra Svoboda; Tatjana Avšič Zupanc; Heikki Henttonen; Alemka Markotić
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

3.  Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment.

Authors:  L Pettersson; T Thunberg; J Rocklöv; J Klingström; M Evander; C Ahlm
Journal:  Clin Microbiol Infect       Date:  2013-06-07       Impact factor: 8.067

4.  HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients.

Authors:  Misa Korva; Ana Saksida; Sabina Kunilo; Blanka Vidan Jeras; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2011-07-20

Review 5.  The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.

Authors:  Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst
Journal:  Clin Kidney J       Date:  2022-01-29

6.  Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses.

Authors:  Sabine Lederer; Erik Lattwein; Merle Hanke; Karen Sonnenberg; Winfried Stoecker; Åke Lundkvist; Antti Vaheri; Olli Vapalahti; Paul K S Chan; Heinz Feldmann; Daryl Dick; Jonas Schmidt-Chanasit; Paula Padula; Pablo A Vial; Raluca Panculescu-Gatej; Cornelia Ceianu; Paul Heyman; Tatjana Avšič-Županc; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04

7.  Genetic detection of dobrava/belgrade virus, bulgaria.

Authors:  Anna Papa; Iva Christova
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

8.  Development of a one-step SYBR Green I real-time RT-PCR assay for the detection and quantitation of Araraquara and Rio Mamore hantavirus.

Authors:  Alex Martins Machado; William Marciel de Souza; Michelly de Pádua; Aline Rafaela da Silva Rodrigues Machado; Luiz Tadeu Moraes Figueiredo
Journal:  Viruses       Date:  2013-09-19       Impact factor: 5.048

Review 9.  Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture.

Authors:  Hong Jiang; Hong Du; Li M Wang; Ping Z Wang; Xue F Bai
Journal:  Front Cell Infect Microbiol       Date:  2016-02-03       Impact factor: 5.293

10.  Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host.

Authors:  Jessica R Spengler; Elaine Haddock; Don Gardner; Brian Hjelle; Heinz Feldmann; Joseph Prescott
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.